NT5C2 and acute lymphoblastic leukemia: Given that NT5C2 expression levels can serve as a prognostic marker in haematological malignancies [157,158] and NT5C2 mutations were linked to ALL [159], it is therefore tempting to deduce that a link between hMOB3s and NT5C2 might be of clinical significance with regard to haematological cancers.